BioWorld Biotechnology State of the Industry Report 2008 : Market Research Report

BioWorld Biotechnology State of the Industry Report 2008

Published: Mar. 1, 2008 - 245 Pages

I. Analysis: 2007 Was the Year of the Deal, as Biotech Reaped Its Reward; The Year in Review; The View from Wall Street; The View from Washington; The View from Europe; The View from the Lab Bench
II. Financial Data: VC Money and Note Deals Boost 2007 Biotech Funding; Money Raised by Biotechnology Companies; Initial Public Offerings; Follow-On Offerings; After-Market Performance (Initial Public Offerings); After-Market Performance (Follow-On Offerings); Initial Public Offerings: 2004-2007 (Gross Proceeds by Month); Follow-On Offerings: 2004-2007 (Gross Proceeds by Month); Gross Proceeds of Biotech Public Stock Offerings: by Quarter 1997-2007; Miscellaneous Financings of Public Biotech Companies; Venture Capital and Other Financings of Private Biotechnology Firms; Milestone Payments and Equity Investments from Corporate Partners; Grants, Contracts and Awards to Biotech Companies
III. Corporate Deals: Tables Turned as Pipeline Squeeze Ups Drug Candidate Ante for Pharma; Biotechnology Mergers and Acquisitions; Biotech-Big Pharma Collaborations: New Agreements; Biotech-Big Pharma Collaborations: Modified and Terminated Agreements; Manufacturing, Marketing and Distribution Agreements with Pharma Companies; Biotech-Biotech Collaborations; Biotech-Biotech Modified and Terminated Agreements; Manufacturing, Marketing and Distribution Agreements Between Biotechnology Companies; Biotech Miscellaneous Collaborations; Deals in Agriculture and Animals.; Biotech-University/Nonprofit Institutions Collaborations
IV. Biotech Product Development: Biotechnology Products Approved by the FDA in 2007; Biotechnology Products on the Market; FDA Actions on Pending Applications in 2007; Licensing Applications Filed and Pending at FDA in 2007; Recommendations by FDA Advisory Panels in 2007; Overseas Approvals and Actions in 2007; Orphan Designations Granted in 2007
V. Report Card For Wall: Methodology Used to Evaluate Underwriter’s Performance; Top 10 Underwriters: Full Credit to Lead Underwriters; Ranked by Gross Proceed; Other Underwriters: Full Credit to Lead Underwriters; Ranked by Gross Proceeds; Top 10 Underwriters: IPOs (Full Credit to All Underwriters, Ranked by Gross Proceeds); Other Underwriters: IPOs (Full Credit to All Underwriters, Ranked by Gross Proceeds; Top 10 Underwriters: IPOs (Full Credit to Lead Underwriters; Ranked By Gross Proceeds); Other Underwriters: IPOs (Full Credit to Lead Underwriters; Ranked by Gross Proceeds); Top 10 Underwriters: IPO (Full Credit to All Underwriters; Ranked by Gross Proceeds); Other Underwriters: IPO (Full Credit to All Underwriters; Ranked by Gross Proceeds); Top 10 Underwriters: IPO (Full Credit to Lead Underwriters; Ranked by After-Market Performance); Other Underwriters: IPO (Full Credit to Lead Underwriters; Ranked by After-Market Performance); Top 10 Underwriters: IPO (Full Credit to All Underwriters; Ranked by After-Market Performance); Other Underwriters: IPO (Full Credit to All Underwriters; Ranked by After-Market Performance)
VI. Stock Perfomance: 2007 Stock Report: an Alphabetical Listing of Public Biotech Companies; 2007 British Stock Report; 2007 Canadian Stock Report; 2007 Price Performance: Biotechnology Stocks Ranked by Percent Change for Year; Tracking the Overall Performance of the 149 Stocks in BioWorld’s Universe; BioWorld Stock Indicator vs. Nasdaq Biotech Index

Abstract

The BioWorld Biotechnology State of the Industry Report 2008 The ultimate industry report measuring the progress of business, science and regulation in biotechnology.

"This comprehensive status report on the biotechnology industry, published by BioWorld Today, is a required reference for analysts and investors in biotech, and is a must-have resource for biotech executives in need of factual data that will help show them which way the sector is heading."

With the BioWorld Biotechnology State of the Industry Report 2008, you can tap into 425 pages of proprietary market research that reveals critical data and financial information about trends affecting the biotechnology industry in the U.S. It contains more than 300 up-to-date tables and charts, plus special analysis sections on Wall Street, the FDA, R&D and biotech in Europe.

The new BioWorld Biotechnology State of the Industry Report 2008 gives you every piece of information available to help you analyze developments in the biotechnology industry and stay ahead of the curve. An example of some of the data you receive includes:

Money raised by biotechnology companies last year
Follow-on public offerings
After-market performance (IPOs)
After-market performance for follow-on offerings
IPOs for the past 4 years
Follow-on offerings for the past 4 years
Gross proceeds of biotech public stock offerings for the past 10 years
Venture capital and other financings of private biotechnology firms
Milestones and equity investments from corporate partners
Grants and awards to biotech companies
New agreements between biotech and big-pharma
Modified and terminated agreements between biotech and big-pharma
Ag-bio collaborations
Manufacturing, marketing and distribution agreements
Biotech and university/nonprofit institution collaborations
Mergers and acquisitions: completed, pending and terminated
And much more!

By combining these tables and charts with expert opinions from industry thought-leaders, the BioWorld Biotechnology State of the Industry Report 2008 is the prerequisite for creating dynamic data-driven presentations, preparing business plans and marketing strategies, and deepening your understanding of the biotechnology industry.

People who need this report:

Biotechnology and pharmaceutical executives
Start-ups
Heads of R&D
Analysts
Investors
Law firms serving the sector
Economic development organizations
Technology transfer officers

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

advertise with us

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

BioWorld Biotechnology State of the Industry Report 2008

Table of Contents

Abstract